GNI Group
We Bring New Hope to LIfe.
IR News
VIEW MOREABOUT US
GNI Group Ltd, headquartered in Japan, is a global healthcare company that engages in the entire value chain—from drug discovery to manufacturing and commercialization—through its consolidated subsidiaries.
Under the vision of "We Bring New Hope to Life," we are committed to delivering hope to patients around the world by developing innovative technologies and products that address unmet medical needs, expanding markets, and bringing new therapies to market.
R&D
GNI group has established operational bases in Japan, China, the U.S., and Australia and primarily conducts drug discovery and clinical development activities in China through its consolidated subsidiaries. Our proprietary drug discovery platform, combined with high-quality and cost-effective operations in China, generates strong synergies and serves as a core strength of our group.
The high-quality and cost effective drug discovery and clinical trials platform in China is one of GNI Group’s main strengths.
Investor
Relations
Sustainability
GNI Group Ltd. and its affiliated companies are committed to sustainability initiatives under the vision of “We Bring New Hope to Life.” Through our business activities, we aim to address social challenges, contribute to achieving the SDGs, and enhance our group’s long-term sustainable growth and corporate value.
